Pramlintide in the Management of Insulin-Using Patients with Type 2 and Type 1 Diabetes

Por Pullman, John, Darsow, Tamara, Frias, Juan P
Publicado em 2006

Review of Adverse Events Associated With False Glucose Readings Measured by GDH-PQQ–Based Glucose Test Strips in the Presence of Interfering Sugars

Por Frias, Juan P., Lim, Christine G., Ellison, John M., Montandon, Carol M.
Publicado em 2010

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycer...

Por Jabbour, Serge A., Frías, Juan P., Guja, Cristian, Hardy, Elise, Ahmed, Azazuddin, Öhman, Peter
Publicado no Diabetes Obes Metab (2018)

A 16-Week Open-Label, Multicenter Pilot Study Assessing Insulin Pump Therapy in Patients with Type 2 Diabetes Suboptimally Controlled with Multiple Daily Injections

Por Frias, Juan P, Bode, Bruce W, Bailey, Timothy S, Kipnes, Mark S, Brunelle, Rocco, Edelman, Steven V
Publicado em 2011

Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabete...

Por Frías, Juan P., Hardy, Elise, Ahmed, Azazuddin, Öhman, Peter, Jabbour, Serge, Wang, Hui, Guja, Cristian
Publicado no Diabetes Obes Metab (2018)

Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

Por Guja, Cristian, Frías, Juan P., Somogyi, Aniko, Jabbour, Serge, Wang, Hui, Hardy, Elise, Rosenstock, Julio
Publicado no Diabetes Obes Metab (2018)

Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Met...

Por Jabbour, Serge A., Frías, Juan P., Hardy, Elise, Ahmed, Azazuddin, Wang, Hui, Öhman, Peter, Guja, Cristian
Publicado no Diabetes Care (2018)

Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled tr...

Por Frías, Juan P., Nakhle, Samer, Ruggles, James A., Zhuplatov, Sergey, Klein, Eric, Zhou, Rong, Strange, Poul
Publicado no Diabetes Obes Metab (2016)

Continuous Subcutaneous Insulin Infusion in Patients With Type 2 Diabetes: A Cohort Study to Establish the Relationship Between Glucose Control and Plasma Oxidized Low Density Lipo...

Por Megson, Ian L., Treweeke, Andrew T., Shaw, Andrew, MacRury, Sandra M., Setford, Steven, Frias, Juan P., Anhalt, Henry
Publicado no J Diabetes Sci Technol (2015)

Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized tria...

Por Henry, Robert R., Frias, Juan P., Walsh, Brandon, Skare, Sharon, Hemming, John, Burns, Colleen, Bicsak, Thomas A., Baron, Alain, Fineman, Mark
Publicado no PLoS One (2018)